Home / Market News / $ABT
benzinga Corporate Catalyst Impact 92/100 ● positive

Abbott To Spin Off Nutrition Business Into Independent Public Company With $8.5B In Annual Sales; Separation Expected To Be Completed By 2027 End

Oct 21, 2026, 11:29 AM UTC · Primary ticker $ABT

Abbott announced its intention to spin off its Nutrition business into a separate, publicly traded company with $8.5 billion in annual sales. This separation aims to unlock distinct growth strategies for both entities, with Abbott focusing on accelerated sales growth and an expanded margin profile, while the new Nutrition company targets the healthy nutrition market.

Abbott is spinning off its Nutrition business, which generates $8.5 billion in annual sales, into a new independent public company. This move is significant because it allows both the remaining Abbott and the new Nutrition company to pursue more focused growth strategies. Abbott expects to achieve accelerated sales growth and an expanded margin profile by shedding the Nutrition segment, while the new company will be a leader in the healthy nutrition market with iconic brands like Similac and Ensure. This is a long-term strategic play, with the separation not expected to be completed until the end of 2027, providing a clear roadmap for investors. For traders, the key opportunity lies in anticipating the valuation of the new Nutrition company and the potential re-rating of Abbott's remaining healthcare business, which could see improved profitability metrics.

$ABT positive Strategic spin-off to enhance focus and margin profile
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.